387 related articles for article (PubMed ID: 9134648)
1. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
2. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
[TBL] [Abstract][Full Text] [Related]
4. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Camani C; Gavin O; Kruithof EK
Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.
Kurokawa T; Iwasa S; Kakinuma A; Stassen JM; Lijnen HR; Collen D
Thromb Haemost; 1991 Dec; 66(6):684-93. PubMed ID: 1796414
[TBL] [Abstract][Full Text] [Related]
7. Clearance receptors for tissue-type plasminogen activator.
Camani C; Kruithof EK
Int J Hematol; 1994 Aug; 60(2):97-109. PubMed ID: 7948967
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
9. Uptake, internalization and degradation of the novel plasminogen activator reteplase (BM 06.022) in the rat.
Kuiper J; van de Bilt H; Martin U; van Berkel TJ
Thromb Haemost; 1995 Dec; 74(6):1501-10. PubMed ID: 8772228
[TBL] [Abstract][Full Text] [Related]
10. The 39-kDa protein regulates LRP activity in cultured endothelial and smooth muscle cells.
Warshawsky I; Schwartz AL
Eur J Cell Biol; 1996 Feb; 69(2):156-65. PubMed ID: 8907616
[TBL] [Abstract][Full Text] [Related]
11. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
Bijsterbosch MK; Ziere GJ; Van Berkel TJ
Mol Pharmacol; 1989 Sep; 36(3):484-9. PubMed ID: 2550781
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.
Van de Werf F; Jang IK; Collen D
J Cardiovasc Pharmacol; 1987 Jan; 9(1):91-3. PubMed ID: 2434801
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
Seydel W; Stang E; Roos N; Krause J
Arzneimittelforschung; 1991 Feb; 41(2):182-6. PubMed ID: 1904231
[TBL] [Abstract][Full Text] [Related]
14. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK
Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523
[TBL] [Abstract][Full Text] [Related]
15. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
16. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
[TBL] [Abstract][Full Text] [Related]
17. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
18. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
Narita M; Bu G; Herz J; Schwartz AL
J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
Rensen PC; Oosten M; Bilt E; Eck M; Kuiper J; Berkel TJ
J Clin Invest; 1997 May; 99(10):2438-45. PubMed ID: 9153287
[TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activator.
Ueshima S; Holvoet P; Lijnen HR; Nelles L; Seghers V; Collen D
Thromb Haemost; 1994 Jan; 71(1):134-40. PubMed ID: 8165632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]